Effect of background long-acting beta-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD
about
Effect of background long-acting beta-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD
description
im Jahr 2018 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
Effect of background long-acti ...... h moderate-to-very-severe COPD
@en
Effect of background long-acti ...... h moderate-to-very-severe COPD
@nl
type
label
Effect of background long-acti ...... h moderate-to-very-severe COPD
@en
Effect of background long-acti ...... h moderate-to-very-severe COPD
@nl
prefLabel
Effect of background long-acti ...... h moderate-to-very-severe COPD
@en
Effect of background long-acti ...... h moderate-to-very-severe COPD
@nl
P2093
P2860
P356
P1476
Effect of background long-acti ...... h moderate-to-very-severe COPD
@en
P2093
Barry Price
Shahin Sanjar
Thomas Goodin
P2860
P304
P356
10.2147/COPD.S172408
P407
P577
2018-01-01T00:00:00Z